Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
Clinical trial NCT00098852 · UNKNOWN
Trial details
- NCT number
- NCT00098852
- Sponsor
- University of California, San Francisco
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2010-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.